{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:32:34Z","timestamp":1794486754393,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":862,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1038\/s41379-020-0532-1","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T04:04:13Z","timestamp":1587355453000},"page":"1690-1701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome"],"prefix":"10.1016","volume":"33","author":[{"given":"Bayan","family":"Alzumaili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4638-9835","authenticated-orcid":false,"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Spanheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Michael","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Katabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snjezana","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ganly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Untch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"Ghossein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-0532-1_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1038\/s41379-020-0532-1_bib2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jcp.19.2.114","article-title":"Histogenesis of medullary carcinoma of the thyroid","volume":"19","author":"Williams","year":"1966","journal-title":"J Clin Pathol"},{"key":"10.1038\/s41379-020-0532-1_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1056\/NEJM196808082790602","article-title":"Medullary carcinoma of the thyroid gland. Studies of thyrocalcitonin in plasma and tumor extracts","volume":"279","author":"Tashjian","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-020-0532-1_bib4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z","article-title":"Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems","volume":"88","author":"Kebebew","year":"2000","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-0532-1_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000493977","article-title":"Trends in diagnostics, surgical treatment, and prognostic factors for outcomes in medullary thyroid carcinoma in Norway: a nationwide population-based study","volume":"8","author":"Opsahl","year":"2019","journal-title":"Eur Thyroid J"},{"key":"10.1038\/s41379-020-0532-1_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40463-018-0303-x","article-title":"Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer","volume":"47","author":"Turkdogan","year":"2018","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1038\/s41379-020-0532-1_bib7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jc.2007-1714","article-title":"Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study","volume":"93","author":"Elisei","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-020-0532-1_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/thy.2014.0277","article-title":"Response to initial therapy predicts clinical outcomes in medullary thyroid cancer","volume":"25","author":"Lindsey","year":"2015","journal-title":"Thyroid"},{"issue":"Suppl 1","key":"10.1038\/s41379-020-0532-1_bib9","first-page":"S627","article-title":"Medullary thyroid carcinoma: prognostic variables and tumour markers affecting survival","volume":"30","author":"Hassan","year":"2018","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"10.1038\/s41379-020-0532-1_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/jcem-19-1-152","article-title":"Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity","volume":"19","author":"Hazard","year":"1959","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-020-0532-1_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF01948712","article-title":"Ein Fall von metastasierenden Amyloidtumoren (Lymphosarkom)","volume":"185","author":"Jaquet","year":"1906","journal-title":"Virchows Arch Pathol Anat Physiol"},{"key":"10.1038\/s41379-020-0532-1_bib12","series-title":"WHO classification of tumours of the lung pleura, thymus and heart.","author":"D. TW, Brambilla E, Burke AP, A. M, G. NA.","year":"2015"},{"key":"10.1038\/s41379-020-0532-1_bib13","series-title":"WHO classification of tumours of endocrine organs","author":"Lloyd","year":"2017"},{"key":"10.1038\/s41379-020-0532-1_bib14","series-title":"Tumor of the thyroid and parathyroid gland (AFIP atlas of tumor pathology series 4)","first-page":"606","author":"Rosai","year":"2015"},{"key":"10.1038\/s41379-020-0532-1_bib15","unstructured":"Amin MB, Edge SB, L. GF, Brookland RK, M. K, E. GJ, et al. AJCC cancer staging manual. 8th edition. Chicago, IL: Springer Nature; 2017."},{"key":"10.1038\/s41379-020-0532-1_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jtho.2016.11.2222","article-title":"Neuroendocrine tumors of the lung: current challenges and advances in the diagnosis and management of well-differentiated disease","volume":"12","author":"Hendifar","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-020-0532-1_bib17","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1007\/s00268-018-4738-z","article-title":"Static prognostic factors and appropriate surgical designs for patients with medullary thyroid carcinoma: the second report from a single-institution study in Japan","volume":"42","author":"Ito","year":"2018","journal-title":"World J Surg"},{"key":"10.1038\/s41379-020-0532-1_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2265.1998.00392.x","article-title":"Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'etude des tumeurs a calcitonine","volume":"48","author":"Modigliani","year":"1998","journal-title":"Clin Endocrinol"},{"key":"10.1038\/s41379-020-0532-1_bib19","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1245\/s10434-014-4208-2","article-title":"Postoperative nomogram for predicting cancer-specific mortality in medullary thyroid cancer","volume":"22","author":"Ho","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-020-0532-1_bib20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1590\/S1807-59322009000900005","article-title":"Prognostic influence of clinical and pathological factors in medullary thyroid carcinoma: a study of 53 cases","volume":"64","author":"Brandao","year":"2009","journal-title":"Clinics"},{"key":"10.1038\/s41379-020-0532-1_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00268-005-7949-z","article-title":"Prognostic factors for sporadic medullary thyroid carcinoma","volume":"30","author":"Gulben","year":"2006","journal-title":"World J Surg"},{"key":"10.1038\/s41379-020-0532-1_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/jcp.19.2.103","article-title":"Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid","volume":"19","author":"Williams","year":"1966","journal-title":"J Clin Pathol"},{"key":"10.1038\/s41379-020-0532-1_bib23","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/1097-0142(19880215)61:4<806::AID-CNCR2820610428>3.0.CO;2-G","article-title":"Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content","volume":"61","author":"Schroder","year":"1988","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-0532-1_bib24","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1556::AID-CNCR20>3.0.CO;2-Y","article-title":"Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables","volume":"77","author":"Dottorini","year":"1996","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-0532-1_bib25","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1245\/s10434-010-1021-4","article-title":"Prognostic value of histological and immunohistochemical characteristics for predicting the recurrence of medullary thyroid carcinoma","volume":"17","author":"Rios","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-020-0532-1_bib26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2559.2008.03002.x","article-title":"Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential","volume":"52","author":"Koperek","year":"2008","journal-title":"Histopathology"},{"key":"10.1038\/s41379-020-0532-1_bib27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1677\/ERC-07-0128","article-title":"Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer","volume":"14","author":"Miccoli","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1038\/s41379-020-0532-1_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0360-3016(83)90093-7","article-title":"Medullary thyroid carcinoma: prognostic factors and treatment","volume":"9","author":"Rougier","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1038\/s41379-020-0532-1_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/thy.1996.6.305","article-title":"Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control","volume":"6","author":"Brierley","year":"1996","journal-title":"Thyroid"},{"key":"10.1038\/s41379-020-0532-1_bib30","first-page":"113","article-title":"Medullary thyroid cancer: prognostic factors for survival and recurrence, recommendations for the extent of lymph node dissection and for surgical therapy in recurrent disease","volume":"8","author":"Pilaete","year":"2012","journal-title":"B-ENT"},{"key":"10.1038\/s41379-020-0532-1_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF01218417","article-title":"Proliferating cell nuclear antigen (PCNA) in medullary thyroid carcinoma","volume":"119","author":"Skopelitou","year":"1993","journal-title":"J Cancer Res Clin Oncol"},{"issue":"Suppl 2","key":"10.1038\/s41379-020-0532-1_bib32","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1038\/modpathol.2010.132","article-title":"Parathyroid tumors and related disorders","volume":"24","author":"DeLellis","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0532-1_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00210956","article-title":"Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register","volume":"71","author":"Raue","year":"1993","journal-title":"Clin Investig"},{"key":"10.1038\/s41379-020-0532-1_bib34","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0046-8177(98)90417-8","article-title":"Medullary thyroid carcinoma: search for histological predictors of survival (109 proband cases analysis)","volume":"29","author":"Franc","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-020-0532-1_bib35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.humpath.2009.08.011","article-title":"Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate\/tumor necrosis): a clinicopathologic and molecular study","volume":"41","author":"Rivera","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-020-0532-1_bib36","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/cncr.21739","article-title":"Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients","volume":"106","author":"Hiltzik","year":"2006","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-0532-1_bib37","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/sj.bjc.6601453","article-title":"The Ki67 index a prognostic marker in medullary thyroid carcinoma","volume":"89","author":"Tisell","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-0532-1_bib38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1309\/HXUNAG34B3CEFDU8","article-title":"Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas","volume":"128","author":"Kim","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-020-0532-1_bib39","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1530\/EJE-11-0079","article-title":"Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification","volume":"164","author":"Mian","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-020-0532-1_bib40","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.bjc.6605056","article-title":"Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas","volume":"100","author":"Moura","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-0532-1_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00428-014-1589-3","article-title":"High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas","volume":"465","author":"Simbolo","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1038\/s41379-020-0532-1_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/thy.2012.0207","article-title":"Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series","volume":"23","author":"Ciampi","year":"2013","journal-title":"Thyroid"},{"key":"10.1038\/s41379-020-0532-1_bib43","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/cen.14060","article-title":"The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: a systematic review","volume":"91","author":"Fussey","year":"2019","journal-title":"Clin Endocrinol"},{"key":"10.1038\/s41379-020-0532-1_bib44","doi-asserted-by":"crossref","first-page":"4915736","DOI":"10.1155\/2017\/4915736","article-title":"Prognostic impact of miR-224 and RAS mutations in medullary thyroid carcinoma","volume":"2017","author":"Cavedon","year":"2017","journal-title":"Int J Endocrinol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0532-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0532-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222006986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222006986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0532-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:40:27Z","timestamp":1760229627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222006986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0893395222006986"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-0532-1","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-0532-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}